Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01GUG
|
||||
| Former ID |
DNC008079
|
||||
| Drug Name |
12-O-deacetyl-12-epi-19-deoxy-21-hydroxyscalarin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529138] | ||
| Formula |
C25H38O4
|
||||
| Canonical SMILES |
CC1(CCCC2(C1CCC3(C2CC(C4(C3CC=C5C4COC5=O)C)O)C)C)CO
|
||||
| InChI |
1S/C25H38O4/c1-22(14-26)9-5-10-23(2)17(22)8-11-24(3)18-7-6-15-16(13-29-21(15)28)25(18,4)20(27)12-19(23)24/h6,16-20,26-27H,5,7-14H2,1-4H3/t16-,17-,18-,19+,20+,22-,23-,24-,25+/m0/s1
|
||||
| InChIKey |
LXWMXTKOJPFGPW-NFXGRNOLSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Bile acid receptor | Target Info | Inhibitor | [529138] | |
| KEGG Pathway | Bile secretion | ||||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.